Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Macrolide Treatment forMycobacterium abscessusandMycobacterium massilienseInfection and Inducible Resistance
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 186, Issue 9, Pages 917-925
Publisher
American Thoracic Society
Online
2012-08-10
DOI
10.1164/rccm.201111-2005oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy of refractory nontuberculous mycobacterial lung disease
- (2012) David E. Griffith et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Serial CT Findings ofMycobacterium massiliensePulmonary Disease Compared withMycobacterium abscessusDisease after Treatment with Antibiotic Therapy
- (2012) Hyun Su Kim et al. RADIOLOGY
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
- (2011) Julie Jarand et al. CLINICAL INFECTIOUS DISEASES
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) T. Mukherjee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
- (2011) Maurizio Renna et al. JOURNAL OF CLINICAL INVESTIGATION
- Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline)
- (2011) Jerry M. Zuckerman et al. MEDICAL CLINICS OF NORTH AMERICA
- Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
- (2011) Jiwon Lyu et al. RESPIRATORY MEDICINE
- Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus
- (2010) Won-Jung Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Thr202Ala in thyA Is a Marker for the Latin American Mediterranean Lineage of the Mycobacterium tuberculosis Complex Rather than Para-Aminosalicylic Acid Resistance
- (2010) S. Feuerriegel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing
- (2010) Sylvaine Bastian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficient Differentiation of Mycobacterium abscessus Complex Isolates to the Species Level by a Novel PCR-Based Variable-Number Tandem-Repeat Assay
- (2010) G.-E. Choi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing
- (2010) Yi-Ching Huang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns
- (2010) Hee-Youn Kim et al. MICROBIOLOGY AND IMMUNOLOGY
- Antibiotic Treatment ofMycobacterium abscessusLung Disease
- (2009) Kyeongman Jeon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease
- (2008) Naoki Hasegawa et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More